Celularity Inc. (CELU) vs Sensus Healthcare, Inc. (SRTS)

A side-by-side comparison of Celularity Inc. and Sensus Healthcare, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CELU vs SRTS

growth of $100 · dividends reinvested · last 7y
CELU -98.3% (-43.9%/yr)SRTS -40.7% (-7.2%/yr)SRTS compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $100202120232025$2$59
CELU SRTS

CELU vs SRTS: by the numbers

  • •SRTS is the larger company ($49M vs $46M market cap).
  • •Both run net losses; SRTS's is the smaller (-88.45% vs -375.77% net margin).
  • •CELU grew revenue faster over the past five years (8.31% vs 2.86% CAGR).

Metrics side by side

Valuation

MetricCELUSRTS
P/S ratio2.412.79
P/B ratioN/A1.33

Profitability

MetricCELUSRTS
Gross margin79.62%36.39%
Operating margin-230.92%-37.50%
Net margin-375.77%-88.45%
ROEN/A-42.01%
ROIC-192.99%-35.63%

Growth (annualized)

MetricCELUSRTS
Revenue CAGR (5Y)8.31%2.86%
Total return CAGR (5Y)-52.57%-4.37%

Frequently asked

Which has grown faster, CELU or SRTS?
Over the past five years, CELU grew revenue faster — CELU at a 8.31% CAGR versus SRTS at 2.86%.
How have CELU and SRTS total returns compared?
Over the past 5 years, CELU delivered -52.57% and SRTS delivered -4.37% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.